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Expanding the Use of RNA in Forensic Science: 
A Quantum Dot Molecular Beacon Approach 
 
Joshua R. Moore 
 
As the popularity of shows such as CSI increases, so does the demand for DNA evidence in court 
cases. This has led to the overwhelming of capacity for analysis of biological samples at crime 
labs across the country, and to the development of a massive backlog of DNA evidence waiting 
to be processed. At the end of 2011, labs had a processing capacity of 250,000 cases per year, but 
an annual total of nearly 350,000 that needed to be processed. Such delays have effects 
throughout the US justice system. One way to reduce the backlog would be to increase the value 
of the evidence retrieved from the scene, reduce the collection of unnecessary evidence, and 
retrieve as much data from the evidence as possible in the fewest steps. We investigated a novel, 
confirmatory method of body fluid identification using quantum dot molecular beacons 
(QDMBs). The QDMBs target RNA species that are tissue-specific or sex-specific, allowing for 
the identification of body fluid stains and identifying the sex of the depositor of a bloodstain. Our 
results show that we were successful in developing QDMBs that identify blood, semen, saliva, 
male blood, and female blood, along with a human-specific beacon. We were also able to detect 
aged stains, although the age detectable is dependent upon the particular fluid tested. This 
technique has a low cost, confirmatory testing, and a high potential for portability, meaning it 
could be performed at the scene to increase the value of evidence retrieved. In addition to being a 
confirmatory test, it does not lead to the degradation of DNA, as can some presumptive tests. We 
believe this technique holds great potential for increasing the value of RNA in forensic evidence 
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The field of forensic science, and DNA analysis in particular, has grown substantially in 
recent years due to advancements in the technologies used for forensic analyses.  Likewise, there 
has been an increase in the amount of evidence collected by crime scene investigators and thus 
an increase in the amount of evidence in need of processing by forensic laboratories. The amount 
of evidence collected and the amount of evidence that can be processed in a given period of time 
have both grown, but at unequal rates, leading to a substantial backlog of evidence waiting for 
processing (1). As this backlog grows, cases take longer to be investigated, trials are delayed, 
and the criminal justice system slows. As of 2011, US labs had the capacity to process almost 
250,000 cases, but had a total DNA case load of almost 350,000 cases. Although the labs are 
increasing their capacity they are still being outpaced by the growth in demand for casework 
services (1).  
There are multiple ways to reduce this backlog and increase the rate at which evidence is 
processed. Some methods include: increasing the employment numbers at crime laboratories to 
increase the volume that can be processed at a given lab; improving the techniques used to 
analyze the evidence such that results can be obtained in a more efficient manner; or, developing 
a method of ensuring only the evidence of highest value is retrieved from the scene and 
processed at the crime laboratory (1, 2).
 
This research explores a possible answer using that third method, of increasing the value 
of evidence retrieved and analyzed. If confirmatory testing is performed in the field, less analysis 
time in the lab will be wasted on preliminary steps, and processing time and effort will be saved. 




of a body fluid stain and confirms the presence of nucleic acids useful for further analysis would 
be of great value. This would increase the value of evidence retrieved and allow field 
investigators to reject samples that add little or no value to the investigation. 
The focus of this research is on body fluid stains, as they are likely to contain DNA 
evidence that can be used to identify suspects and connect a suspect to the scene or to the victim. 
It is true that many tests for certain body fluids already exist, but there are not confirmatory tests 
for each body fluid (3, 4). Also, many of these confirmatory tests can only be performed in an 
equipped forensic lab and not in the field (4-7). Portable presumptive tests may give false 
positives, or worse, false negatives for body fluids. Additionally, some presumptive tests have 
negative effects on the stains, affecting the DNA results later in the process (8). This could result 
in waste of analysts’ time through the necessity of further confirmatory testing or the rejection of 
evidence due to it being falsely believed a non-body-fluid stain with no relevance to the 
investigation. And at the time of this writing, there is no confirmatory test for the presence of 
saliva (3, 4).
 
One way to develop a confirmatory method of body fluid identification would be to look 
for molecular species that are unique to a particular body fluid. While DNA can provide 
individually-identifiable information for evidence, it is almost universally present in tissues and 
cannot provide information on the body fluid source of a stain. RNA, on the other hand, is 
generally present in much higher concentrations than DNA and has variability based on tissue 
identity. Additionally, RNA can be co-isolated with DNA, reducing consumption of the evidence 
and potentially increasing the speed of the workflow (9, 10). Using a confirmatory technique that 
relies on nucleic acids avoids the risk of presumptive techniques that would degrade the sample, 




Thus, the goal of identifying a stain could be achieved through the use of RNA species 
that are only expressed in a given body fluid, or have alternatively-spliced variants that are 
processed differently for a given body fluid. Tissue-specific RNA species have been used 
previously for body fluid identification (11-13). The caveat to these past techniques is that they 
rely on polymerase chain reaction (PCR) for identification of the tissue-specific RNA species. 
PCR is highly useful and accurate in the identification of body fluids, but it also requires 
specialized equipment and training, and is a time-consuming process. 
Another method of identifying these tissue-specific RNA species would be to use a 
particular kind of probe that only binds and fluoresces in the presence of a target RNA species. 
Molecular Beacons (MB) are a form of nanotechnology that can function as this type of probe. 
MBs are short sequences of DNA or RNA designed to bind to a target sequence and that have a 
quencher or fluorophore on either end and small flanking sequences that result in self-folding 
into a hairpin shape (Figure 1; 14). These MBs are stable in this hairpin shape and do not 
fluoresce, but if mixed with the target RNA they will unfold, bind the target, and produce a 
positive signal in the form of fluorescence. If, however, the molecular beacon is mixed with a 
non-target RNA, it stays in the hairpin shape and reveals no increased fluorescence. 
Specifically, the proposed MBs use a quantum dot (QD) fluorophore. QDs were chosen 
because they have a much higher fluorescence than traditional organic fluorophores, and are 
highly stable as well (15, 16). The specific quantum dots used have a CdSe core with a ZnS 
coating. The wavelength of fluorescence is based on the size of the CdSe core, and the intensity 
of the fluorescence increases with the wavelength (Table 1; 17). This product would be known as 
a quantum dot molecular beacon (QDMB), to be distinguished from traditional MBs; the 




This reaction between the QDMB and the target RNA occurs at room temperate in a short 
amount of time and requires only a small fluorospectrometer and a laptop for determination of 
the response. If combined with a fast spin-column extraction technique, analysis of potential 
body fluids resulting in a confirmatory response can occur in as little as 30 minutes. Such a 
technique would also require only a minimum of training compared to PCR-based analysis. As 
such, it is believed this holds great potential for increasing the value of evidence retrieved by 
ensuring that evidence collected and returned to the crime laboratory is of actual scientific value.  
This evidentiary value can be increased further if greater information is able to be 
retrieved from the sample using the same technique. It has been established that tissue-specific 
RNA species can be used for body fluid identification, but there may be more information that 
can be derived from the RNA in the stains. For instance, if the sex of the ‘donor’ could be 
determined at the scene, this may provide an investigative lead and will give more information to 
direct the continued processing of the evidence. This method also has the potential for detecting 
mixtures of fluids, which can affect the later processing as well.  
The main objective of this thesis is to refine past research upon QDMBs for body fluid 
identification and to expand their usefulness as a forensic analytical technique. A rapid test for 
body fluid identification and determination of sex of the person that deposited the stain may be a 
great boon to investigators by helping narrow down which evidence may be of the highest value 
to the investigation. The preliminary detection limitations of this technique were also tested, 






Figure 1: A traditional molecular beacon and its method of function. Upon ‘discovery’ of its target sequence, it is more stable to 
unfold from the hairpin and bind to the target, resulting in fluorescence. GeneLink, 2015. 
 
Figure 2: Theoretical structure of QDMB. Note the multiple quenchers attached to the QD fluorophore. The red box represents 
biotin and the green shapes are the streptavidin, which are responsible for the conjugation. Courtesy of Dr. Stephanie Young. 
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Analysis of Tissue-Specific RNA 
The development of this methodology began with the identification of tissue-specific 
RNAs. An extensive review of the literature was undertaken to choose candidate genes that 
display tissue-specific expression or tissue-specific alternative splice variants. After selection of 
candidate genes, PCR primers were designed to confirm the tissue-specificity of the RNA. If an 
mRNA was found to not be tissue specific, it was rejected, and the literature search continued. 
This was repeated until a tissue-specific RNA was found for each body fluid or subject of 
interest (Table 2). 
The blood, saliva, and human-specific beacons were developed as part of past research in 
the Bishop lab (26). The rationale for their selection was based on published data and the 
citations are included in Table 2. The male-specific beacon was originally believed to be semen-
specific, but further testing showed that the gene variant selected, originally thought to be a 
splice variant only found in testes, is also found in male blood. XIST was chosen as the female-
specific beacon due to its role in the X-inactivation process and recent research showing that it is 
significantly upregulated in the female blood transcriptome (24, 25). 
Development of Molecular Beacons 
Once target RNAs were chosen, molecular beacons were designed based on those RNAs. 
The MBs were designed to target exon junctions so that the beacons would not bind DNA 
instead and thus no longer be tissue-specific. Lengths of 20-25 nt were chosen, similar to PCR 
primers, as this length provides specificity and stability to the target-beacon complex. The short 
flanking sequences were then added to allow self-folding, but they are sufficiently short such that 




is present. Molecular beacons were synthesized according to established protocols for 
streptavidin-biotin-linked MBs with few modifications (27).  
2’-O-Methyl-RNA oligonucleotides modified with an Iowa Black quencher on the 3’ end 
and a 5’ biotin linker were obtained from Integrated DNA Technologies (Coralville, IA). The 
sequence of each oligonucleotide was designed to incorporate the complementary sequence of 
the forward primer used in the previous PCR--based screen, and these sequences can be found in 
Table 3. Six nucleotides of complementary sequence were designed to flank either end of the 
oligonucleotide to create the stem portion of the MB. Streptavidin-coated QDs were obtained 
from Life Technologies (Carlsbad, CA). The RNA species, the emission wavelengths of the QD 
label, and the corresponding quencher molecule used for each body fluid can be found in Table 
3. 
Conjugation of Molecular Beacons to Quantum Dots 
As the molecular beacon oligos were received from a different source than the quantum 
dot fluorophores, they needed to be conjugated in the lab. This conjugation technique was a 
modification of the technique used by Cady (27). Twenty-five pmol of the chosen QD, 1 mmol 
of the MB oligo, and QD incubation buffer to a final volume of 400 μL were combined in a 
sterile 1.5 mL tube. This mixture was incubated at room temperature for one hour. A Millipore 
Amicon 50K spin-column membrane was wet by adding 100 μL of QD buffer and running in a 
centrifuge at 13,000 xg for 1 minute. The flow-through of this step was discarded. Once the 
incubation was complete, the 400μL QD/oligo mixture was added to the Millipore spin column, 
and centrifuged at 13,000 xg for 5 minutes. This flow-through was reserved for fluorescence 
analysis. The flow-through was analyzed on the fluorospectrometer to test for any fluorescence 




conjugation is highly efficient. The spin column was washed twice using 400 μL of the buffer, 
and centrifuged at 13,000 xg for 5 minutes each time. The spin column was placed upside-down 
in a collection tube, and centrifuged at 1000 g for 2 minutes to collect the QDMBs. A significant 
reduction of fluorescence was observed between the QD and the conjugated QDMB, as the 
conjugation was successful. 
Analysis of Sample Using QDMBs 
For analysis of a sample, 20 μL of RNA was combined with 2 μL of the QDMB solution 
and incubated for 10 minutes. This mixture was analyzed by pipetting 2 μL onto the pedestal of 
the NanoDrop 3300 (ThermoScientific). The blank for analysis was 2 μL nuclease-free water, the 
background fluorescence was established using 2 μL QDMB in 20 μL water, and the positive 
control was 2 μL of unquenched QD in 20 μL water.  
Specificity of QDMBs 
 Each QDMB was tested for specificity by combining QDMBs with fresh RNA extracted 
from blood, semen, and saliva. Extractions were performed using the manufacturer’s protocol for 
TRI-Reagent BD, using 30 µL of the given body fluid (MRC, Inc., Cincinnati, OH). Once 
extracted, the RNA was analyzed using the protocol given above.  
Aging of Samples 
 As the initial step in determining limits of detection for this technique, samples of each 
body fluid (blood, semen, and saliva) were deposited upon fabric, allowed to dry, and aged for a 
predetermined time period in the lab under ambient conditions. Samples were aged for 0, 1, 3, 7, 





Results of each step were analyzed using one-way ANOVA followed by Tukey-Kramer 
HSD, to test whether that there was a significant difference between positive and negative results 
with each beacon. ANOVA including Dunnet’s test was performed for the data of the aging 
study, as this will show the significance relative to a control.  
Table 2: RNA identities and primer sequences for body fluid identification. 






[20] Yes FP: 5’- AGCATGGAAGAAAAAGAGAGAAAGA -3’ 
RP: 5’- TCTTCACCAGGGGAGGTCCT -3’ 
Saliva EMP1
[21] No FP: 5’- ACCCTTCAGAACTCTCTTTGCTCA -3’ 
RP: 5’- AACGCCGATGATGAAGCTG -3’ 
Semen SG
[22] 
No FP: 5’- ATGGGACAAAAAGGTGGATCA -3’ 
RP: 5’- GACTTTTTCGGGACTGGTCA -3’ 
Male-specific hHK1
[23] 
Yes FP: 5’- GCAAGGACAGTGCGTTCAAGA -3’ 
RP: 5’- CCGCATGGCATAGAGATACTTG -3’ 
Female-specific XIST
[24, 25] 
No FP: 5’- CTCTTTAGAATACTGATCCCATT -3’ 





No FP: 5’- CCATCCATGTACGTTGCTATCCAGGCTGT -3’ 
RP: 5’- GCAGCCGTGGCCATCTC -3’ 
 
Table 3: Body fluid specific RNA identities with QD wavelength, quencher, and beacon sequence. The underlined portion 
represents the self-complementary stem that leads to the formation of the molecular beacon hairpin structure. 
RNA QD Iowa 
Black 
Quencher 
MB Oligonucleotide Sequence 
4.1R 585 nm FQ 5’- CCCGGAUCUUUCUCUCUUUUUCUUCCAUGCUUCCGGG -3’ 
EMP1 605 nm RQ 5’- CCCGGAUGAGCAAAGAGAGUUCUGAAGGGUUCCGGG - 3’ 
SG 585 nm FQ 5’- CCCGGAAUGGGACAAAAAGGUGGAUCAUCCGGG - 3’ 
hHK1 655 nm RQ 5’- CCCGGAUCUUGAACGCACUGUCCUUGCUCCGGG - 3’ 
XIST 625 nm RQ 5’- CCCGGACUCUUUAGAAUACUGAUCCCAUUUCCGGG - 3’ 







Effective Conjugation of MB to QD 
The attachment of the biotinylated MB containing an Iowa Black quencher molecule to 
the streptavidin-coated QD resulted in a reduction of fluorescence. Effective conjugation is 
demonstrated in Figure 3, where a reduction in fluorescence of the QDMB is demonstrated 
relative to the QD alone. The semen QDMB showed the greatest level of quenching, with a 93% 
reduction in fluorescence. The blood QDMB showed the lowest level of quenching, with a 
reduction in fluorescence of 55%. The saliva and human-specific QDMBs showed a 64% and 
66% reduction in fluorescence, respectively. The female QDMB showed 87% quenching, while 
the male QDMB displayed 82% quenching effectiveness.  
Tissue Specificity of Conjugated QDMBs 
The QDMBs only showed a significant increase in fluorescence when combined with 
their appropriate target RNA and did not show a significant increase when combined with non-
target RNA species (Fig. 4). This demonstration of increasing fluorescence when only in contact 
with target RNA species can also be seen in Figure 5, where error bars are included. It should be 
noted that the sex-specific beacons did not identify saliva. Saliva is not separated by sex because 
the sex-specific beacons do not give a response to saliva. For this study, n=14 saliva donors, 7 
female blood donors, 7 male blood donors, and 4 semen donors. 
An ANOVA analysis with Tukey-Kramer HSD was also performed on the data, to 
provide statistical support for the conclusions observed. Each beacon tested resulted in a p-value 




fluorescence. The analytical results of the statistical analysis for the female-specific beacon are 
provided as an example of the output (Figure 6). The other analytical outputs can be found in 
Appendix 1.  
Effectiveness Using Aged Samples 
 Results were mixed for the testing of effectiveness with aged samples. Blood and saliva 
were only detectable for 3 days, based on the design of the study. Semen was detectable for 7 
days. The male and female beacons were both detectable in blood at 14 days; they may persist 
longer but the study only contained samples for 14 days of testing. It is of note that the male 
beacon displayed an upward trend in the fluorescence level with the length of time of aging of 
the sample. This may be coincidence, or an effect of the aging process. It should also be noted 
that the male and female beacons were used to test aged blood samples, and not stains of other 
fluids. For this study, n=3 samples from one donor per fluid per day. 
 The statistical analysis of the aged samples supports the conclusions reached from the 
graphing. The female-specific and male-specific beacons displayed a p-value of <0.0001 for each 
aging period, when compared to the control in ANOVA. The blood-specific beacon displayed a 
p-value of <0.0001 for days 0, 1, and 3, while days 7 and 14 were not significantly different from 
the control, meaning a negative response. The semen-specific beacon displayed a p-value of 
<0.0001 for days 0, 1, 3, and 7, while day 14 was not significantly different from the control. The 
saliva-specific beacon displayed a p-value of <0.0001 for days 0, 1, 3, and 7, while day 14 was 
not significantly different from the control. The caveat to this is that while day 7 was 
significantly different from the control, it was actually due to lower RFU readings, still meaning 
























Figure 3: Relative fluorescence of QD versus QDMB. The relative fluorescence of each QD (in black) is compared to that of the 
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Figure 4: Tissue specificity testing of QDMBs. These graphs demonstrate that the QDMBs only give fluorescence increases 
above background when in contact with RNA from the target body fluid. A: Blood, B: Saliva, C: Semen, D: Female, E: Male, F: 
Human. N=14 saliva donors, 7 female blood donors, 7 male blood donors, 4 semen donors. 
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Figure 5: A comparison of target and non-target QDMB fluorescence expression. The QDMB displays a significant increase in 
fluorescence only when combined with the target RNA, and shows little or no increase relative to background when combined 
with non-target RNA. N=14 saliva donors, 7 female blood donors, 7 male blood donors, 4 semen donors. P<0.0001 for each 
positive result, as determined by ANOVA (See Figure 7 and Appendix). 
 
Figure 6: Results of aging of samples in days, tested with tissue-specific beacon. N= 3 samples from one donor per fluid per day. 
P-values reported in text.   






































The purpose of this study was to continue development of a novel, confirmatory method 
of body fluid identification. The development of such a technique would reduce the amount of 
evidence retrieved while increasing the quality, and thus ease the workflow for evidence analysis 
in crime laboratories. The results of this study confirm that tissue-specific RNAs can be targeted 
to determine the biological make-up of a stain without the use of PCR. This study also shows 
that the sex of the person can be determined from a bloodstain, without the use of PCR or other 
time-consuming techniques (28, 29). The presented method, especially once optimized in 
multiplex, may help to reduce the amount of backlog that is currently plaguing crime laboratories 
nationwide. 
The MB oligonucleotides were linked to their QDs using biotin-streptavidin interactions. 
The QDMBs were tested for proper conjugation using an assay in which quenching of the 
fluorophore was measured. It was determined that all MB oligonucleotides containing a 
quencher molecule had been correctly coupled to the corresponding QD. The fluorescence of 
certain QDMBs was more highly quenched than others, exhibiting a range of 97.4% to 48.3% 
reduction in fluorescence. As the QDMBs are not all equally quenched, there is room for further 
optimization. This variation is likely the result of natural differences in the fluorescence levels of 
the QDs, and the number of quenching MB probes attached to each QD (Figure 2). Each 
wavelength of QD has a different fluorescence intensity, which can be a challenge in quenching. 
Further refinement of the attachment chemistry to increase the quenching of the QDs will lead to 





Refinement of the assay may also increase the viability of multiplexing of the reactions. 
Understanding the functioning of the probes in singleplex is useful; however, a multiplex of 
reactions will shorten the amount of time necessary for sample analysis and reduce the amount of 
RNA necessary for analysis. There is also room for improvement on the basis of the binding of 
the QDMB to the target RNA. While RNA is generally visualized as a line, such as in Figure 1, 
in reality it tends to have secondary structure complicating this binding process. One possibility 
would be to heat the RNA and break hydrogen bonds holding the secondary structure; however, 
some preliminary work shows that heating the QDMB denatures the streptavidin-biotin linkage 
and eliminates the effectiveness of the QDMB.  
Once optimized, there is room for further development and experimentation. Further 
study of the effect of aging of samples on the results could be performed to determine if there are 
reliable trends, and to determine what is causing the early drop-out of certain RNA species. If the 
trends are consistent across longer and larger studies, however, the results of the test could 
provide a rough estimate of the time of deposit of the stain. Past research using PCR-based 
techniques have shown that RNA can be detected in body fluid stains after longer periods of 
aging and can be used to determine the age of the stain (30, 31). Considering that the RNAs are 
known to exist for longer periods of time and are detectable using PCR, there may be some 
factor in the aging that affects the binding and fluorescence of the QDMB specifically. Also, 
there is the potential for the development of more QDMBs that could be incorporated into the 
technique to identify other tissue-specific RNA species of interest.  
There are caveats to the sex-specificity beacons that can be controlled. Primarily, these 
are chromosomal disorders such as Turner’s and Klinefelter’s Syndromes. Turner’s is an XO 




live births worldwide (32). A Turner female would not express XIST and thus would not test 
positive for our female-specific beacon; however, they would not test positive for the male-
specific, either. A bloodstain that does not test positive for either sex-specific beacon could be 
logically surmised to be from a female with Turner’s syndrome. Klinefelter’s syndrome is a 
phenotypic male with multiple X chromosomes in addition to a Y chromosome, and occurs in 1 
in 500 to 1000 live male births (33). A person with Klinefelter’s would theoretically test positive 
for both sex-specific beacons and lead to the conclusion it is a mixed sample; later STR testing 
would confirm that it is in fact a single male donor.  
We believe this technique offers multiple advantages in comparison to current 
presumptive and confirmatory tests for body fluid identification. Our technique can be used to 
process multiple samples in less than hour and does not require PCR. Without the requirement 
for PCR, the equipment, cost, and training required for the technique are all reduced. The cost of 
a multiplex reaction, combining the three body fluids with a human-specific beacon, would be 
approximately $10 per sample for this technique. Including the sex-specific beacons would only 
be an increase of $1-2 per sample. The technique provides a confirmatory answer to the identity 
of a body fluid or mixture of fluids, compared to at least two separate lab tests required to 
determine this currently. This may also be the first confirmatory technique for saliva that does 
not rely upon PCR. In addition, the technique can identify the sex of the depositor of a blood 
stain, which currently requires PCR analysis. This technique also does not degrade the DNA of a 
sample, as will some presumptive tests (8). Overall, this technique has the potential to be a 
highly useful tool in the reduction of the national DNA backlog and improving the value of RNA 
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